A smarter way to build vaccines: Scientists harness AI to target emerging alphaviruses

A team of scientists at The University of Texas Medical Branch (UTMB), led by Nikos Vasilakis, Ph.D., and Peter McCaffrey, MD, has developed a new computational pipeline that could dramatically accelerate the development of vaccines against a group of mosquito-borne viruses known as alphavirus. Vasilakis is a professor and the vice chair for research, and McCaffrey is an assistant professor of clinical practice and director of the UTMB AI center, both in the Department of Pathology. The work was conducted in collaboration with the researchers' colleagues in Brazil and Panama.